EGFR and lung carcinoma: (45)developed an innovative AI system known as the Fully Automated Artificial Intelligence System (FAIS) to predict EGFR gene mutations in lung cancer, as well as to assess the progression-free survival (PFS) of patients receiving EGFR-targeted therapy.